Form D · Biotechnology
SOURCE PRECISION MEDICINE, INC.
Bounder, CO · CIK 0001077396
Offering snapshot reported Aug 26, 2010 · SEC filing
- Reported sold
- $500K Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 11, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 26, 2010 | Initial | $500,000 | No comparison | 2 | SEC filing |
| Feb 23, 2010 | Initial | $1,509,123 | No comparison | 20 | SEC filing |
| Sep 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 10, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-146950
Promissory Notes and Warrants to Purchase Common Stock.
Source: Form D, filed Aug 26, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| J. Terence Carleton | Director |
| Karl Wassman | Director, Executive |
| Karl Wassmann | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2500 Central Avenue Suite H 2
Bounder, CO, 80301
Bounder, CO, 80301